441
Views
1
CrossRef citations to date
0
Altmetric
Articles

Robust analyzes for longitudinal clinical trials with missing and non-normal continuous outcomes

, , , &
Pages 1-14 | Received 11 Oct 2022, Accepted 16 Sep 2023, Published online: 26 Sep 2023

References

  • Carpenter, J. R., Roger, J. H., & Kenward, M. G. (2013). Analysis of longitudinal trials with protocol deviation: a framework for relevant, accessible assumptions, and inference via multiple imputation. Journal of Biopharmaceutical Statistics, 23(6), 1352–1371. https://doi.org/10.1080/10543406.2013.834911
  • Carroll, R. J., & Pederson, S. (1993). On robustness in the logistic regression model. Journal of the Royal Statistical Society. Series B, Statistical Methodology, 55(3), 693–706.
  • Chang, L., Roberts, S., & Welsh, A. (2018). Robust lasso regression using Tukey's biweight criterion. Technometrics, 60(1), 36–47. https://doi.org/10.1080/00401706.2017.1305299
  • Cro, S., Morris, T. P., Kenward, M. G., & Carpenter, J. R. (2016). Reference-based sensitivity analysis via multiple imputation for longitudinal trials with protocol deviation. The Stata Journal, 16(2), 443–463. https://doi.org/10.1177/1536867X1601600211
  • Elashoff, R., Li, G., Li, N., & Tseng, C. H. (2012). Robust inference for longitudinal data analysis with non-ignorable and non-monotonic missing values. Statistics and its Interface, 5(4), 479–490. https://doi.org/10.4310/SII.2012.v5.n4.a11
  • Fox, J., & Monette, G. (2002). An R and S-Plus companion to applied regression. Sage.
  • Guan, Q., & Yang, S. (2019). A unified framework for causal inference with multiple imputation using martingale. arXiv:1911.04663.
  • Henry, K., Erice, A., Tierney, C., Balfour, H. H., Fischl, M. A., Kmack, A., Liou, S. H., Kenton, A., Hirsch, M. S., Phair, J., & Martinez, A. (1998). A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. Journal of Acquired Immune Deficiency Syndromes, 19(4), 339–349. https://doi.org/10.1097/00042560-199812010-00004
  • Huber, P. J. (1973). Robust regression: Asymptotics, conjectures and Monte Carlo. Annals of Statistics, 1(5), 799–821. https://doi.org/10.1214/aos/1176342503
  • Huber, P. J. (2004). Robust statistics (Vol. 523). John Wiley & Sons.
  • ICH (2021). E9(R1) statistical principles for clinical trials: Addendum: Estimands and sensitivity analysis in clinical trials. FDA Guidance Documents.
  • Jaeckel, L. A. (1972). Estimating regression coefficients by minimizing the dispersion of the residuals. The Annals of Mathematical Statistics, 1449–1458. https://doi.org/10.1214/aoms/1177692377
  • Kelly, G. E. (1992). Robust regression estimators-the choice of tuning constans. Journal of the Royal Statistical Society Series D: The Statistician, 41(3), 303–314.
  • Leurent, B., Gomes, M., Cro, S., Wiles, N., & Carpenter, J. R. (2020). Reference-based multiple imputation for missing data sensitivity analyses in trial-based cost-effectiveness analysis. Health Economics, 29(2), 171–184. https://doi.org/10.1002/hec.v29.2
  • Little, R., & Yau, L. (1996). Intent-to-treat analysis for longitudinal studies with drop-outs. Biometrics, 1324–1333. https://doi.org/10.2307/2532847
  • Little, R. J. (1993). Pattern-mixture models for multivariate incomplete data. Journal of the American Statistical Association, 88(421), 125–134.
  • Little, R. J., D'Agostino, R., Cohen, M. L., Dickersin, K., Emerson, S. S., Farrar, J. T., Frangakis, C., Hogan, J. W., Molenberghs, G., Murphy, S. A., & Neaton, J. D. (2012). The prevention and treatment of missing data in clinical trials. N Engl J Med, 367(14), 1355–1360. https://doi.org/10.1056/NEJMsr1203730
  • Liu, G. F., & Pang, L. (2016). On analysis of longitudinal clinical trials with missing data using reference-based imputation. Journal of Biopharmaceutical Statistics, 26(5), 924–936. https://doi.org/10.1080/10543406.2015.1094810
  • Liu, S., Yang, S., Zhang, Y., & Liu, G. F. (2022). Sensitivity analysis in longitudinal clinical trials via distributional imputation. Statistical Methods in Medical Research, 32(1), 181–194. https://doi.org/10.1177/0962280222113525
  • Mack, M. J., Leon, M. B., Thourani, V. H., Makkar, R., Kodali, S. K., Russo, M., Kapadia, S. R., Malaisrie, S. C., Cohen, D. J., Pibarot, P., & Leipsic, J. (2019). Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med, 380(18), 1695–1705. https://doi.org/10.1056/NEJMoa1814052
  • Mallinckrodt, C., Lin, Q., & Molenberghs, M. (2013). A structured framework for assessing sensitivity to missing data assumptions in longitudinal clinical trials. Pharmaceutical Statistics, 12(1), 1–6. https://doi.org/10.1002/pst.1547
  • Mehrotra, D. V., Li, X., Liu, J., & Lu, K. (2012). Analysis of longitudinal clinical trials with missing data using multiple imputation in conjunction with robust regression. Biometrics, 68(4), 1250–1259. https://doi.org/10.1111/j.1541-0420.2012.01780.x
  • Meyer, G. P. (2021). An alternative probabilistic interpretation of the huber loss. In Proceedings of the IEEE/CVF conference on computer vision and pattern recognition (pp. 5261–5269). IEEE Computer Society.
  • Miao, W., Gel, Y. R., & Gastwirth, J. L. (2006). A new test of symmetry about an unknown median. In Random walk, sequential analysis and related topics: A festschrift in honor of Yuan-Shih Chow (pp. 199–214). World Scientific.
  • Mogg, R., & Mehrotra, D. V. (2007). Analysis of antiretroviral immunotherapy trials with potentially non-normal and incomplete longitudinal data. Statistics in Medicine, 26(3), 484–497. https://doi.org/10.1002/(ISSN)1097-0258
  • O'Neil, P. M., Birkenfeld, A. L., McGowan, B., Mosenzon, O., Pedersen, S. D., Wharton, S., Carson, C. G., Jepsen, C. H., Kabisch, M., & Wilding, J. P. (2018). Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. The Lancet, 392(10148), 637–649. https://doi.org/10.1016/S0140-6736(18)31773-2
  • Ratitch, B., O'Kelly, M., & Tosiello, R. (2013). Missing data in clinical trials: from clinical assumptions to statistical analysis using pattern mixture models. Pharmaceutical Statistics, 12(6), 337–347. https://doi.org/10.1002/pst.1549
  • Robins, J. M., & Wang, N. (2000). Inference for imputation estimators. Biometrika, 87(1), 113–124. https://doi.org/10.1093/biomet/87.1.113
  • Rosenblum, M., & Van Der Laan, M. J. (2009). Using regression models to analyze randomized trials: Asymptotically valid hypothesis tests despite incorrectly specified models. Biometrics, 65(3), 937–945. https://doi.org/10.1111/j.1541-0420.2008.01177.x
  • Rubin, D. B. (1976). Inference and missing data. Biometrika, 63(3), 581–592. https://doi.org/10.1093/biomet/63.3.581
  • Rubin, D. B. (2004). Multiple imputation for nonresponse in surveys (Vol. 81). John Wiley & Sons.
  • Sadeghkhani, A., Peng, Y., & Lin, C. D. (2019). A parametric Bayesian approach in density ratio estimation. Stats, 2(2), 189–201. https://doi.org/10.3390/stats2020014
  • Smola, A. J., & Schölkopf, B. (2004). A tutorial on support vector regression. Statistics and Computing, 14(3), 199–222. https://doi.org/10.1023/B:STCO.0000035301.49549.88
  • Sun, Q., Zhou, W. X., & Fan, J. (2020). Adaptive huber regression. Journal of the American Statistical Association, 115(529), 254–265. https://doi.org/10.1080/01621459.2018.1543124
  • Takeuchi, I., Bengio, Y., & Kanamori, T. (2002). Robust regression with asymmetric heavy-tail noise distributions. Neural Computation, 14(10), 2469–2496. https://doi.org/10.1162/08997660260293300
  • Tan, P. T., Cro, S., Van Vogt, E., Szigeti, M., & Cornelius, V. R. (2021). A review of the use of controlled multiple imputation in randomised controlled trials with missing outcome data. BMC Medical Research Methodology, 21(1), 1–17. https://doi.org/10.1186/s12874-021-01261-6
  • Tang, Y. (2017). An efficient multiple imputation algorithm for control-based and delta-adjusted pattern mixture models using SAS. Statistics in Biopharmaceutical Research, 9(1), 116–125. https://doi.org/10.1080/19466315.2016.1225595
  • US Food and Drug Administration (2016). Statistical review and evaluation of Tresiba and Ryzodeg 70/30. Retrieved May 26, 2016, from https://www.fda.gov/media/102782/download.
  • Yang, S., & Kim, J. K. (2016). A note on multiple imputation for method of moments estimation. Biometrika, 103(1), 244–251. https://doi.org/10.1093/biomet/asv073
  • Yang, S., Zhang, Y., Liu, G. F., & Guan, Q. (2021). SMIM: A unified framework of survival sensitivity analysis using multiple imputation and martingale. Biometrics. https://doi.org/10.1111/biom.13555
  • Ye, Y., Gao, J., Shao, Y., Li, C., Jin, Y., & Hua, X. (2020). Robust support vector regression with generic quadratic nonconvex ε-insensitive loss. Applied Mathematical Modelling, 82, 235–251. https://doi.org/10.1016/j.apm.2020.01.053